HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 23, No 05, May 2019 – What's Cracking Antibodies in ostrich eggs       » China to amend healthcare laws       » First "one-minute clinic" in China university       » Australian gene-editing rules adopt 'middle ground'       » Brexit leads to 25 per cent decline in UK clinical trials       » Wheat that fights celiac disease      
INSIDE INDUSTRY
Brexit leads to 25 per cent decline in UK clinical trials
QPS Netherlands ready to take on clinical trials that require relocation, manage new projects

According to a recent report by Fitch Solutions, Brexit is already impacting the UK’s clinical trials environment.

The number of clinical trials taking place in the UK has declined by more than 25 per cent since British voters elected to leave the EU in 2016.

With Brexit pending and the European Medicines Agency (EMA) headquarters moving from London to the Netherlands, QPS, a global contract research organization (CRO) providing discovery, preclinical and clinical drug development services, announced it is ready to take on clinical trials that need to relocate and is prepared to manage new projects in the Netherlands, Austria and around the globe.

“There are concerns about how medicines will be approved in the UK after Brexit, as well as how MHRA will operate as a stand-alone agency and how the EMA will manage data generated in the UK. As a result, companies are beginning to suspend clinical trial activities across the UK,” said Marc Thouin, president and general manager of QPS in the Netherlands.

The Netherlands is a great location to host a clinical research site, as it is home the new EMA headquarters, is a top R&D innovation hub for biopharmaceutical companies, has one of the world’s highest-ranking healthcare systems, several research institutes, and more than 100 biotech companies.

Click here for the complete issue.

NEWS CRUNCH  
news Which country has the worst sleepers
news Asia is the fastest growing region for nutraceuticals
news 2018 Nobel Prize in Physiology or Medicine winners
news Vitafoods Asia expands by 40 per cent in 2018
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
February:
Marijuana as medicine — Legal marijuana will open up scientific research
March:
Driven by curiosity
April:
Career developments for researchers
May:
What's cracking — Antibodies in ostrich eggs
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy